Log in
Enquire now

List of Chroma Therapeutics patents

List of Chroma Therapeutics patents
List of Turtle Beach Corporation patents
List of ZeroPoint Technologies AB patents
List of Sift Science patents
CEOs of business process automation companies
List of SaaS companies in Canada
Patents where
Current Assignee
Name
is
‌
Chroma Therapeutics
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 8637547 Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases

Patent 8637547 was granted and assigned to Chroma Therapeutics on January, 2014 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8637547
January 28, 2014
‌
US Patent 8686032 Enzyme inhibitors

Patent 8686032 was granted and assigned to Chroma Therapeutics on April, 2014 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8686032
April 1, 2014
‌
US Patent 9604940 2-aminopyrazine derivatives as CSF-1R kinase inhibitors

Patent 9604940 was granted and assigned to Chroma Therapeutics on March, 2017 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9604940
March 28, 2017
‌
US Patent 9388136 Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof

Patent 9388136 was granted and assigned to Chroma Therapeutics on July, 2016 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9388136
July 12, 2016
‌
US Patent 8217050 Adenine derivative as inhibitors of HSP90 for the treatment of cancer

Patent 8217050 was granted and assigned to Chroma Therapeutics on July, 2012 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8217050
July 10, 2012
‌
US Patent 9133104 Enzyme inhibitors

Patent 9133104 was granted and assigned to Chroma Therapeutics on September, 2015 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
9133104
September 15, 2015
‌
US Patent 8211900 DHFR enzyme inhibitors

Patent 8211900 was granted and assigned to Chroma Therapeutics on July, 2012 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8211900
July 3, 2012
‌
US Patent 8778953 Inhibitors of P38 map kinase

Patent 8778953 was granted and assigned to Chroma Therapeutics on July, 2014 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
8778953
July 15, 2014
‌
US Patent 7074578 Methods and means of histone methylation

Patent 7074578 was granted and assigned to Chroma Therapeutics on July, 2006 by the United States Patent and Trademark Office.

‌
Chroma Therapeutics
United States Patent and Trademark Office
United States Patent and Trademark Office
7074578
July 11, 2006
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us